A Study of Teclistamab in Participants With Relapsed or Refractory Multiple Myeloma
Clinical trial NCT04557098 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT04557098
- Sponsor
- Janssen Research & Development, LLC
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-09-17
- Primary completion
- 2021-11-09
- Enrollment
- 194
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.